OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

NLRP3 and cancer: Pathogenesis and therapeutic opportunities
Isak W. Tengesdal, Charles A. Dinarello, Carlo Marchetti
Pharmacology & Therapeutics (2023) Vol. 251, pp. 108545-108545
Closed Access | Times Cited: 15

Showing 15 citing articles:

Harnessing Pyroptosis for Cancer Immunotherapy
Christopher M. Bourne, Cornelius Y. Taabazuing
Cells (2024) Vol. 13, Iss. 4, pp. 346-346
Open Access | Times Cited: 7

An updated systematic review about various effects of microplastics on cancer: A pharmacological and in-silico based analysis
Akmaral Baspakova, Afshin Zare, Roza Suleimenova, et al.
Molecular Aspects of Medicine (2025) Vol. 101, pp. 101336-101336
Closed Access

Caspase-1 activation, IL-1/IL-6 signature and IFNγ-induced chemokines in lungs of COVID-19 patients
Audrey Cambon, Christophe Guervilly, Clémence Delteil, et al.
Frontiers in Immunology (2025) Vol. 15
Open Access

Astragalus Polysaccharide Regulates Epithelial-mesenchymal Transition in HepG2 Liver Cancer Cells by Inhibiting NLRP3 Inflammasome Activation
Hongtao Sui, Xiangliang Yang, Zongyuan Huang, et al.
Pharmacognosy Magazine (2025)
Closed Access

Inflammation in cancer: therapeutic opportunities from new insights
Yifei Xie, Fangfang Liu, Yunfei Wu, et al.
Molecular Cancer (2025) Vol. 24, Iss. 1
Open Access

The critical role of NLRP3 in drug resistance of cancers: Focus on the molecular mechanisms and possible therapeutics
Beena Briget Kuriakose, Ahmed Hussein Zwamel, Ayad Abdulrazzaq Mutar, et al.
Seminars in Oncology (2025) Vol. 52, Iss. 1, pp. 27-40
Closed Access

Exosomal HMGB3 released by glioma cells confers the activation of NLRP3 inflammasome and pyroptosis in tumor-associated macrophages
Ping Hu, Tengfeng Yan, Shigang Lv, et al.
Tissue and Cell (2024) Vol. 88, pp. 102406-102406
Closed Access | Times Cited: 3

Screening NLRP3 drug candidates in clinical development: lessons from existing and emerging technologies
Isak W. Tengesdal, Migachelle Banks, Charles A. Dinarello, et al.
Frontiers in Immunology (2024) Vol. 15
Open Access | Times Cited: 2

Cytokine-armed pyroptosis induces antitumor immunity against diverse types of tumors
Sara Orehek, Taja Železnik Ramuta, Duško Lainšček, et al.
Nature Communications (2024) Vol. 15, Iss. 1
Open Access | Times Cited: 2

Advancements in Predictive Medicine: NLRP3 Inflammasome Inhibitors and AI-Driven Predictive Health Analytics
Robert B. Kargbo
ACS Medicinal Chemistry Letters (2024) Vol. 15, Iss. 3, pp. 331-333
Open Access | Times Cited: 1

The Effects of Caloric Restriction on Inflammatory Targets in the Prostates of Aged Rats
Vittoria Rago, Francesco Conforti, Daniele La Russa, et al.
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 10, pp. 5236-5236
Open Access | Times Cited: 1

Thiolutin Alleviates Cardiotoxic Effects of Doxorubicin by Suppressing NLRP3 Inflammasome in the Mouse Model
Wenyuan Cai, Tingting Teng, Xiaoyan Wang, et al.
Cardiovascular Toxicology (2024)
Closed Access | Times Cited: 1

Identification of Anti-Inflammatory and Anti-Cancer Compounds Targeting the NF-κB-NLRP3 Inflammasome Pathway from a Phytochemical Library of the Sideritis Genus
Rümeysa Yücer, Andreas Schröder, Gülaçtı Topçu, et al.
Journal of Ethnopharmacology (2024) Vol. 338, pp. 119074-119074
Open Access

Inflammasomes and idiopathic inflammatory myopathies
Rui Sun, Jiyan Chu, Ping Li
Frontiers in Immunology (2024) Vol. 15
Open Access

Page 1

Scroll to top